Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | JNK-IN-8 | 3.0 | uM | Visfatin | 1 | ng/mL | 2 | GRO-a | 3097.5 | 68 | |
N2586 | JNK-IN-11 | 0.3 | uM | Visfatin | 1 | ng/mL | 2 | GRO-a | 5839.0 | 31 | |
0 | GRO-a | 34.5 | 72 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | GRO-a | 16003.5 | 68 | ||||
RA2159 | EO1428 | 1.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | GRO-a | 12548.0 | 53 | |
RA2159 | PI103 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 2 | GRO-a | 11051.0 | 34 | |
RA2159 | Sigma A6730 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | GRO-a | 13058.0 | 50 | |
RA2159 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | GRO-a | 5854.0 | 72 | |
RA2159 | JNK-IN-11 | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | GRO-a | 14016.0 | 59 | |
N2586 | Poly(I:C) | 2 | ug/mL | 2 | GRO-a | 16608.0 | 63 | ||||
N2586 | EO1428 | 1.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | GRO-a | 14609.0 | 49 | |
N2586 | PI103 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 2 | GRO-a | 16926.0 | 51 | |
N2586 | Sigma A6730 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | GRO-a | 16224.0 | 44 | |
N2586 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | GRO-a | 11216.5 | 56 | |
N2586 | JNK-IN-11 | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | GRO-a | 13281.0 | 64 | |
0 | GRO-a | 46.0 | 79 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 14826.0 | 51 | ||||
RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 13655.0 | 83 | |
RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 8069.0 | 73 | |
RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 14674.0 | 55 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 13095.0 | 76 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 6488.5 | 58 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 17826.0 | 74 | ||||
N2586 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 18864.0 | 77 | |
N2586 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 18134.0 | 50 |